Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2019 Feb 11;19:135. doi: 10.1186/s12885-019-5316-y

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s). 2019

Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

PMC Copyright notice

Fig. 5 — a Complete response to neoadjuvant therapy with absence of malignant cells and replacement of malignant cells by hyalinized fibrous tissue (thin arrow). Complete response to neoadjuvant therapy with absence of malignant cells and replacement of malignant cells by hyalinized fibrous tissue (thin arrow) and atrophied breast lobule (arrow head). c Incomplete response to neoadjuvant therapy with few residual clusters of invasive ductal carcinoma (arrow head) and replacement of tumor cells by hyalinized fibrous tissue (thin arrow). d Incomplete response to neoadjuvant therapy with few residual clusters of invasive ductal carcinoma (arrowhead). e Incomplete response to neoadjuvant therapy with clusters of residual invasive ductal carcinoma (arrowhead). f Incomplete response to neoadjuvant therapy with residual clusters of invasive ductal carcinoma (arrowhead). g Incomplete response to neoadjuvant therapy with many residual clusters of invasive ductal carcinoma (arrowhead). h Incomplete response to neoadjuvant therapy with sheets of residual invasive ductal carcinoma (arrowhead)